NCT05277051 2026-03-23First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Active not recruiting152 enrolled
NCT05980416 2025-11-14Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2Elevation OncologyPhase 1 Terminated88 enrolled 18 charts